Real-World Effectiveness and Patient Stratification for Vedolizumab Treatment in Crohn’s Disease: A Multicenter Retrospective Study
VDZ was effective and safe in treating Crohn's disease. Patients who were bio-naïve, without active intestinal fistulas, and who had milder baseline disease activity were more likely to benefit from VDZ therapy.
Authors
- Xiang Gao (ORCID: https://orcid.org/0000-0002-3058-4655)
- Zhaopeng Huang (ORCID: https://orcid.org/0009-0002-7689-6520)
- Kang Chao (ORCID: https://orcid.org/0000-0003-2342-0422)
- Qian Cao (ORCID: https://orcid.org/0000-0002-1732-8817)
- Jing Liu (ORCID: https://orcid.org/0000-0002-8188-2396)
- Lingya Yao (ORCID: https://orcid.org/0000-0002-5850-1217)
- Hongsheng Yang (ORCID: https://orcid.org/0000-0002-9803-2929)
- Minhu Chen (ORCID: https://orcid.org/0000-0001-8181-0846)
- Yun Qiu (ORCID: https://orcid.org/0009-0004-6732-2108)
- Ren Mao
Institutions
- Sun Yat-sen University (CN)
- Sir Run Run Shaw Hospital (CN)
- Sixth Affiliated Hospital of Sun Yat-sen University (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
Publication Details
- Journal
- Gastroenterology report
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1093/gastro/goaf096
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Sun Yat-sen University
- Fundamental Research Funds for the Central Universities
- Basic and Applied Basic Research Foundation of Guangdong Province